The groundbreaking approach of the medication represents a major advance in the handling of the condition. Unlike existing drugs, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide329201.blogdiloz.com/40538113/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment